HelpDementia.com has published practical, research-based articles on brain health and aging since 2019. Our editors cover Alzheimer’s disease, vascular dementia, Lewy body dementia, cognitive testing, medications, and family caregiving — informed by the National Institute on Aging, the Alzheimer’s Association, the CDC, and peer-reviewed research.
Explore Our Guides
Latest Articles
- Copper-Based Alzheimer’s Drugs in Mice: Benefits and Risks
Copper-targeting drugs reduce Alzheimer’s plaques in mice but carry toxicity risks that haven’t been solved in humans. - Bipolar Medications in Alzheimer’s Research: What the Science SaysBipolar medications are being researched in Alzheimer’s disease, but evidence for cognitive benefits remains limited—and safety concerns matter for elderly patients.
- Medicare Coverage for Donanemab: Costs and Coverage
Medicare covers Kisunla (donanemab) starting July 2024, but actual out-of-pocket costs and eligibility requirements are more complex than the coverage announcement suggests. - Medicare Coverage for Lecanemab: What It May Cost
Medicare covers Leqembi for early Alzheimer’s, but your out-of-pocket cost depends entirely on your insurance—from $26,500/year to nearly nothing. - Alzheimer’s Infusion Treatment: Before, During, and After
Before starting, patients undergo cognitive testing and amyloid PET imaging to confirm amyloid accumulation in the brain. - Anti-Amyloid Drugs: Benefits
Anti-amyloid drugs slow cognitive decline by about 27%, gaining roughly 4 months of preserved thinking in early Alzheimer’s disease—modest but meaningful for some. - Donanemab Eligibility: Who May Qualify and What Monitoring Is Required
Donanemab eligibility hinges on early cognitive decline plus confirmed brain amyloid and tau pathology, with ongoing infusions paired with rigorous MRI and PET surveillance to detect brain changes. - Galantamine for Alzheimer’s: Benefits
Galantamine slows Alzheimer’s progression in early-stage disease by preserving brain communication, though benefits are modest and individual responses vary. - Rivastigmine Patch: How It Works, Who Uses It, and Skin-Care Tips
The rivastigmine patch delivers dementia medication through your skin in a steady 24-hour dose, but skin irritation and proper application require careful attention. - Donepezil Side Effects: A Family Guide
Donepezil causes nausea, vivid dreams, and heart rhythm changes in many patients—here’s what families need to know. - Alzheimer’s Medications List: Approved Options
Donepezil, rivastigmine, and memantine are approved to slow cognitive decline, though no cure exists and results vary widely. - Mindfulness for Dementia Caregivers: Key Facts
Mindfulness trains dementia caregivers to observe stress without being overwhelmed by it, using brief daily practices that fit within caregiving demands.
